The company's patented technology in the field of optical coherence tomography (OCT) is capable of delivering high-quality, high-resolution cross-sectional tissue images in real-time, allowing tissue structure to be observed up to 2-3 mm below the surface with remarkable clarity and without biopsy or the use of radiation, UV light, or image contrast agents. Tomophase is focused on the development and commercialization of its patented technology for minimally invasive opto-medical devices.